Synthetic multiphase systems
US-10570181-B2 · Feb 25, 2020 · US
US10858402B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10858402-B2 |
| Application number | US-202016736505-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 7, 2020 |
| Priority date | Aug 19, 2014 |
| Publication date | Dec 8, 2020 |
| Grant date | Dec 8, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A synthetic multiphase product including an isolated biofilm surface layer protein A (BslA), wherein the BslA has the amino acid sequence set forth in SEQ ID NO: 28 or a variant thereof that is at least 80% identical to SEQ ID NO: 28.
Opening claim text (preview).
The invention in which an exclusive property or privilege is claimed is defined as follows: 1. A synthetic multiphase product comprising from 0.005 to 0.2 wt % of an isolated biofilm surface layer protein A (BslA), wherein the BslA has the amino acid sequence set forth in SEQ ID NO: 28 or an amino acid sequence that is at least 80% identical to SEQ ID NO: 28, and wherein the synthetic multiphase product further comprises at least one co-surfactant. 2. The synthetic multiphase product of claim 1 , wherein the synthetic multiphase product is a multiphase food product. 3. The synthetic multiphase product of claim 1 , wherein the synthetic multiphase product is a personal care product. 4. The synthetic multiphase product of claim 1 comprising at least three or more intimately mixed phases of matter. 5. The synthetic multiphase product of claim 4 , wherein the synthetic multiphase product comprises a pharmaceutical active agent. 6. A frozen synthetic multiphase product comprising from 0.005 to 0.2 wt % of an isolated BslA, wherein the BslA has the amino acid sequence set forth in SEQ ID NO: 28 or a variant thereof that is at least 80% identical to SEQ ID NO: 28, and wherein the synthetic multiphase product further comprises at least one co-surfactant. 7. The frozen synthetic multiphase product of claim 6 , wherein the at least one co-surfactant is a protein surfactant. 8. The frozen synthetic multiphase product of claim 6 comprising one or more additional components, wherein the one or more additional components comprises one or more of milk proteins, sugars, carbohydrates, egg proteins and fats.
Proteins, e.g. albumin · CPC title
Emulsifier · CPC title
Foams; Dry foams (edible foams A61K9/0056) · CPC title
from Bacillus (G) · CPC title
Aerated, foamed, cellular or porous products · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.